Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biomaterials company Etex has entered into a supply agreement with LifeNet Health, a biomedical alloengineering organization.
Subscribe to our email newsletter
Under the agreement, LifeNet Health will provide Etex with demineralized bone matrix (DBM) powder to be mixed with Etex’s proprietary calcium phosphate to form a bone graft substitute material called EquivaBone. Etex will manufacture EquivaBone in its Cambridge facilities and market the product through its newly formed direct distribution channel. EquivaBone combines the osteoinductive properties of DBM with the fast setting and osteoconductive properties of synthetic calcium phosphate.
Brian Ennis, CEO of Etex, said: “Etex is excited to offer surgeons an osteoinductive bone graft material with enhanced performance and handling characteristics.”